Table 4.
Echocardiographic follow-up findings and overall outcomes of LM
| Number | Sex | Age (years) | Echocardiography | First echocardiography follow-up | Last echocardiography follow-up (time) | Overall outcomes |
|---|---|---|---|---|---|---|
| 1 | Male | 28 | LVEF 19% global WMA of BV VD of BV | LVEF 44% PR in WMA PR in VD | LVEF 45% PR in WMA with more improvement PR in VD (7 months later) | Improved |
| 2 | Female | 23 | LVEF 20% global WMA of BV VD of BV | LVEF 50% PR in WMA CR in VD | LVEF 59% CR in WMA CR in VD (17 months later) | Improved |
| 3 | Female | 24 | LVEF 20% global WMA of BV VD of BV | LVEF 47% PR in WMA no change in VD | LVEF 50% CR in WMA CR in VD (4 months later) | Improved |
| 4 | Female | 32 | LVEF 28% global WMA of LV (severe) | LVEF 72% CR in WMA | NA | Improved |
| 5 | Female | 23 | LEVF 30% segmental to global WMA of LV | LVEF 29% deterioration in WMA | LVEF 33% more deterioration in WMA (6 weeks later) | Deterioration |
| 6 | Female | 53 | LVEF 30% global WMA of LV (severe) VD of LV | LVEF 41% PR in WMA PR in VD | LVEF 52% CR in WMA CR in VD (2 months later) | Improved |
| 7 | Male | 34 | LVEF 32% segmental to global WMA of LV VD of BV | LVEF 33% no change in WMA no change in VD | NA | Improved |
| 8 | Female | 39 | LVEF 33% global WMA of LV (severe) VD of LV | NA | NA | Leave the hospital |
| 9 | Female | 27 | LVEF 34% global WMA of LV (moderate) VD of LV | LVEF 37% no change in WMA | NA | Improved |
| 10 | Female | 24 | LVEF 36% global WMA of LV (moderate) VD of LV | LVEF 56% CR in WMA CR in VD | LVEF 55% CR in WMA CR in VD (63 months later) | Improved |
| 11 | Female | 22 | LVEF 38% global WMA of LV (moderate) VD of LV | LVEF 51% CR in WMA PR in VD | LVEF 54% CR in WMA CR in VD (4 months later) | Improved |
| 12 | Female | 66 | LVEF 40% segmental to global WMA of LV | LVEF 54% CR in WMA | LVEF 60% recurrence in WMA (10 months later) | Recurrence |
| 13 | Female | 26 | LVEF 42% segmental WMA of LV VD of LV | LVEF 47% no change in WMA no change in VD | LVEF 42% deterioration in WMA no change in VD (6 weeks later) | Improved |
| 14 | Female | 17 | LVEF 45% global WMA of LV (moderate) | LVEF 58% CR in WMA | NA | Improved |
| 15 | Female | 13 | LVEF 45% global WMA of LV (mild) | NA | NA | Leave the hospital |
| 16 | Female | 32 | LVEF 45% global WMA of LV (moderate) | NA | NA | Improved |
| 17 | Female | 10 | LVEF 46% global WMA of LV (moderate) | LVEF 63% CR in WMA | LVEF 64% CR in WMA (5 weeks later) | Improved |
| 18 | Female | 23 | LVEF 46% global WMA of LV (moderate) | LVEF 66% CR in WMA | NA | Improved |
| 19 | Female | 26 | LVEF 46% global WMA of LV (moderate) | LVEF 69% CR in WMA | NA | Improved |
| 20 | Female | 25 | LVEF 48% segmental WMA of LV VD of LV | LVEF 47% CR in WMA PR in VD | NA | Improved |
| 21 | Female | 39 | LVEF 48% global WMA of LV (mild) VD of LV | LVEF 57% CR in WMA no change in VD | NA | Improved |
| 22 | Female | 20 | LVEF 49% global WMA of LV (mild) | LVEF 45% no change in WMA | LVEF 73% CR in WMA (67 months later) | Improved |
| 23 | Female | 19 | LVEF 49% global WMA of LV (moderate) VD of LV | LVEF 54% PR in WMA no change in VD | LVEF 49% PR in WMA CR in VD (6 months later) | Improved |
| 24 | Male | 39 | LVEF 50% segmental WMA of LV | Died | ||
| 25 | Female | 16 | LVEF 56% segmental WMA of LV | NA | NA | Leave the hospital |
LM: Lupus myocarditis; LVEF: Left ventricular ejection fraction; WMA: Wall motion abnormality; BV: Both ventricles; VD: Ventricular dilation; LV: Left ventricle; PR: Partial recovery; CR: Complete recovery; NA: Not available.